SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Under the authorization, the Lyra® Direct SARS-CoV-2 Assay does not require an upfront sample extraction. The Lyra® Direct SARS-CoV-2 Assay uses a reformulated buffer that replaces extraction with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results